A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.

Autor: Eteläinen TS; Division of Pharmacology and Pharmacotherapy/Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland., Silva MC; Chemical Neurobiology Laboratory, Departments of Neurology and Psychiatry, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Uhari-Väänänen JK; Division of Pharmacology and Pharmacotherapy/Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland., De Lorenzo F; Division of Pharmacology and Pharmacotherapy/Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland., Jäntti MH; Division of Pharmacology and Pharmacotherapy/Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland., Cui H; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio 70211, Finland., Chavero-Pieres M; Division of Pharmacology and Pharmacotherapy/Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland., Kilpeläinen T; Division of Pharmacology and Pharmacotherapy/Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland., Mechtler C; Division of Pharmacology and Pharmacotherapy/Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland., Svarcbahs R; Division of Pharmacology and Pharmacotherapy/Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland., Seppälä E; School of Medicine / Biomedicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio 70211, Finland., Savinainen JR; School of Medicine / Biomedicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio 70211, Finland., Puris E; Institute of Pharmacy and Molecular Biotechnology, Ruprecht Karls University, Heidelberg D-69120, Germany., Fricker G; Institute of Pharmacy and Molecular Biotechnology, Ruprecht Karls University, Heidelberg D-69120, Germany., Gynther M; Institute of Pharmacy and Molecular Biotechnology, Ruprecht Karls University, Heidelberg D-69120, Germany., Julku UH; Division of Pharmacology and Pharmacotherapy/Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland., Huttunen HJ; Neuroscience Center, University of Helsinki, Helsinki 00014, Finland.; Herantis Pharma Plc., Espoo 02600, Finland., Haggarty SJ; Chemical Neurobiology Laboratory, Departments of Neurology and Psychiatry, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA., Myöhänen TT; Division of Pharmacology and Pharmacotherapy/Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio 70211, Finland.

Publikováno v: Science translational medicine [Sci Transl Med] 2023 Apr 12; Vol. 15 (691), pp. eabq2915. Date of Electronic Publication: 2023 Apr 12.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

α,ω-Oligosilyl Dianions and Their Application in the Synthesis of Homo- and Heterocyclosilanes

Autor: Fischer, R., Frank, D., Gaderbauer, W., Kayser, C., Mechtler, C., Baumgartner, J., Marschner, C.

Publikováno v: Organometallics; September 2003, Vol. 22 Issue: 18 p3723-3731, 9p

Multifunctional Intrinsically Disordered Regions in Transcription Factors.

Autor: Már, Matti¹ (AUTHOR), Nitsenko, Kateryna¹ (AUTHOR), Heidarsson, Pétur O.¹ (AUTHOR) pheidarsson@hi.is

Publikováno v: Chemistry - A European Journal. 4/13/2023, Vol. 29 Issue 21, p1-19. 19p.